Senior insider sale
ORIC PHARMACEUTICALS, INC. — senior position signals high conviction
$270.2K
21.50K shares
What this filing means
HEYMAN RICHARD A. plans to sell 21.50K shares of ORIC PHARMACEUTICALS, INC. valued at approximately $270.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001968582-26-001030
Director
Since Apr 2020
21.50K
Shares to sell
$270.2K
Approx. market value
8.10K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
Stock Option Exercise
Cash
10/1/2026
3.50KStock Option Exercise
Cash
8/25/2016
4.60KTotal acquired8.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2026 | Stock Option Exercise Cash | 3.50K | — |
8/25/2016 | Stock Option Exercise Cash | 4.60K | — |
| Total | 8.10K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
6.85K
Market value
$82.3K
7/24/2026
—Completed
Units to sell
6.25K
Market value
$75.1K
7/24/2026
—Completed
Units to sell
150.00
Market value
$1.8K
7/6/2026
—Completed
Units to sell
150.00
Market value
$1.8K
7/6/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
8.10K
Market value
$109.1K
10/1/2026
Total
Units
21.50K
Value
$270.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/24/2026 | 6.85K | $82.3K | — | Completed |
7/24/2026 | 6.25K | $75.1K | — | Completed |
7/6/2026 | 150.00 | $1.8K | — | Completed |
7/6/2026 | 150.00 | $1.8K | — | Completed |
| Planned — Approximate Date | ||||
10/1/2026 | 8.10K | $109.1K | Nasdaq | Planned |
| Total | 21.50K | $270.2K | ||